Shyam Srinivas, MD, PhD

216.444.2666

Shyam Srinivas, MD, PhD

Appointed: 2006

Shyam Srinivas, MD, PhD
Department: Nuclear Medicine
Vice Chair
Location: Cleveland Clinic Main Campus
Mail Code Jb3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2666
WorkFax:216.444.3943
Shyam Srinivas, MD, PhD
Department: Nuclear Medicine
Location: Cleveland Clinic Main Campus
Mail Code Jb3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2666
WorkFax:216.444.3943
Shyam Srinivas, MD, PhD
Department: Diagnostic Radiology
Location: Cleveland Clinic Main Campus
Mail Code Jb3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2666
WorkFax:216.444.3943
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Shyam M. Srinivas, MD, PhD, is an Associate Staff member in the Nuclear Medicine Department at Cleveland Clinic. He completed his residency training in nuclear medicine at the University of Pennsylvania in Philadelphia, after a preliminary year of internal medicine internship at Christiana Care in Newark, Del. He is board-certified by both the American Board of Nuclear Medicine and the Certification Board of Nuclear Cardiology.

Dr. Srinivas graduated from the University of California, Irvine, where he simultaneously pursued an MD and PhD in an NIH-sponsored Medical Scientist Training Program. The purpose of such a program is to produce physician scientists who can directly apply basic science to the medical field and further the art of medicine through research. His PhD was granted from the Department of Electrical Engineering specializing in biomedical optics at the Beckman Laser Institute at UC Irvine, while working on a new optical imaging technique known as optical coherence tomography.

With a background in optical imaging, a transition to nuclear medicine and molecular imaging was natural for Dr. Srinivas. His major research interests are to continue to explore the potential benefits of hypoxia imaging both in cardiac and oncologic applications. He has interests in using combined PET/CT imaging to guide radiation therapy planning, as well as development of new novel radiotracers. With his engineering background, he also has a keen interest in instrumentation and device development and has helped validate the clinical use of a prototype dedicated breast PET scanner. 

Dr. Srinivas helped co-found and co-directs the Center for PET and Molecular Imaging at Cleveland Clinic. 

Professional Highlights

  • Co-Director and Co-Founder, Center for PET and Molecular Imaging, Aug. 2007-Present

  • Principal Investigator at Cleveland Clinic for industry-sponsored study (Wilex): A Comparative Study of PET/CT versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients with Renal Masses Using Iodine-124 labeled Chimeric G250 (124I-cG250)

     

Education & Fellowships

Residency - Hospital of the University of Pennsylvania
Nuclear Medicine
Philadelphia, PA USA
2006
Internship - Christiana Care
Internal Medicine
Newark, DE USA
2003
Doctorate - University of California at Irvine
Irvine, CA USA
2002
Medical School - University of California-Irvine College of Medicine
Irvine, CA USA
2001
Undergraduate - University of California-San Diego
La Jolla, CA USA
1992

Certifications

  • Nuclear Medicine
  • Certification Board of Nuclear Cardiology

Specialty Interests

cardiac PET, hypoxia imaging, breast cancer detection, optical imaging, instrumentation, and PET/CT for radiation therapy planning

Memberships

  • Society of Nuclear Medicine (SNM)

  • Radiological Society of North America (RSNA)

  • American College of Radiology (ACR)

  • American Society of Nuclear Cardiology (ASNC)

  • Indo-American Society of Nuclear Medicine (IASNM)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/26/2013, Dr. Srinivas has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Srinivas received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Bayer Healthcare Pharmaceuticals, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site